Bharat Biotech’s Covaxin has got WHO approval as the technical advisory team has recommended the India-made vaccine for emergency use listing for 18 years and above. This marks a major victory for India’s journey in vaccination against Covid-19. Covaxin is a vaccine, completely ‘made in India’, by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research. WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson 7 Johnson – Janssen, Moderna, and Sinopharm for emergency use.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The emergency listing got delayed last month as the technical advisory group sought some additional clarification from Bharat Biotech for its final risk assessment. The technical advisory group met to take the final call, and Covaxin has been recommended for emergency use listing. Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.
Important takeaways for all competitive exams:
Weekly Current Affairs One-Liners Current Affairs 2026 plays a very important role in competitive examinations…
Valleys are low areas of land that lie between hills or mountains. They are formed…
Sandwiches are one of the most popular foods in the world. They are simple, quick…
The Government of India has appointed Rohit Jain as the Deputy Governor of the Reserve…
The Government of India has notified the Citizenship (Amendment) Rules, 2026 and introduced the important…
The Reserve Bank of India have announced that 98.47% of ₹2,000 Indian currency notes have…